Literature DB >> 1401214

New selective medium for isolating Clostridium difficile from faeces.

S T Aspinall1, D N Hutchinson.   

Abstract

AIMS: To compare CCFA (cycloserine, cefoxitin fructose agar) with a new selective medium CDMN (containing cysteine hydrochloride, norfloxacin, and moxalactam) for the isolation of Clostridium difficile after direct faecal culture.
METHODS: The minimum inhibitory concentration (MIC) of norfloxacin was determined for 64 strains of C difficile, 17 strains of other Clostridium sp, and 66 various isolates of faecal origin, together with MIC determinations of moxalactam against the 81 strains of Clostridium sp and 15 isolates of Bacteroides sp. Using C difficile agar base with 0.5 g/l of cysteine hydrochloride, norfloxacin and moxalactam were incorporated into the medium and compared with CCFA for the isolation of C difficile after direct faecal culture.
RESULTS: Norfloxacin (12 mg/l) inhibited the growth of enterobacteriaceae and faecal streptococci; moxalactam (32 mg/l) inhibited the growth of most strains of Bacteroides sp tested, together with Clostridium sp other than C difficile. Using the antibiotics in combination (CDMN), the growth and colonial morphology of 64 strains of C difficile were unaffected. When CDMN medium was compared with CCFA for the isolation of C difficile from 832 faeces from inpatients with diarrhoea, the CDMN agar isolated 20% more strains and reduced the number of contaminating colonies by 30%.
CONCLUSIONS: CDMN both improves the isolation rate of C difficile from faecal specimens and reduces the growth of other organisms compared with CCFA.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1401214      PMCID: PMC495111          DOI: 10.1136/jcp.45.9.812

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  9 in total

1.  Effect of antibiotic concentration in a selective medium on the isolation of Clostridium difficile from faecal specimens.

Authors:  P N Levett
Journal:  J Clin Pathol       Date:  1985-02       Impact factor: 3.411

Review 2.  Clostridium difficile: its disease and toxins.

Authors:  D M Lyerly; H C Krivan; T D Wilkins
Journal:  Clin Microbiol Rev       Date:  1988-01       Impact factor: 26.132

3.  Identification of Clostridium difficile using the API ZYM system.

Authors:  P N Levett
Journal:  Eur J Clin Microbiol       Date:  1985-10       Impact factor: 3.267

Review 4.  Anaerobic infections and Clostridium difficile colitis emerging during antibacterial therapy.

Authors:  S M Finegold
Journal:  Scand J Infect Dis Suppl       Date:  1986

5.  Comparison of API ZYM system with API AN-Ident, API 20A, Minitek Anaerobe II, and RapID-ANA systems for identification of Clostridium difficile.

Authors:  C B Head; S Ratnam
Journal:  J Clin Microbiol       Date:  1988-01       Impact factor: 5.948

6.  Selective and differential medium for isolation of Clostridium difficile.

Authors:  W L George; V L Sutter; D Citron; S M Finegold
Journal:  J Clin Microbiol       Date:  1979-02       Impact factor: 5.948

7.  Clostridium difficile and its cytotoxin in feces of patients with antimicrobial agent-associated diarrhea and miscellaneous conditions.

Authors:  W L George; R D Rolfe; S M Finegold
Journal:  J Clin Microbiol       Date:  1982-06       Impact factor: 5.948

8.  Cultures for Clostridium difficile in stools containing a cytotoxin neutralized by Clostridium sordellii antitoxin.

Authors:  S H Willey; J G Bartlett
Journal:  J Clin Microbiol       Date:  1979-12       Impact factor: 5.948

9.  Rapid detection and presumptive identification of Clostridium difficile by p-cresol production on a selective medium.

Authors:  K D Phillips; P A Rogers
Journal:  J Clin Pathol       Date:  1981-06       Impact factor: 3.411

  9 in total
  15 in total

1.  Evaluation of three rapid assays for detection of Clostridium difficile toxin A and toxin B in stool specimens.

Authors:  H Rüssmann; K Panthel; R-C Bader; C Schmitt; R Schaumann
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2007-02       Impact factor: 3.267

2.  Evaluation of three enzyme immunoassays and a loop-mediated isothermal amplification test for the laboratory diagnosis of Clostridium difficile infection.

Authors:  M J Bruins; E Verbeek; J A Wallinga; L E S Bruijnesteijn van Coppenraet; E J Kuijper; P Bloembergen
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2012-06-17       Impact factor: 3.267

3.  Evaluation of a chromogenic culture medium for isolation of Clostridium difficile within 24 hours.

Authors:  John D Perry; Kerry Asir; Diane Halimi; Sylvain Orenga; Joanne Dale; Michelle Payne; Ruth Carlton; Jim Evans; F Kate Gould
Journal:  J Clin Microbiol       Date:  2010-08-25       Impact factor: 5.948

4.  Effective and reduced-cost modified selective medium for isolation of Clostridium difficile.

Authors:  Michelle M Nerandzic; Curtis J Donskey
Journal:  J Clin Microbiol       Date:  2008-12-10       Impact factor: 5.948

5.  Clostridioides difficile uses amino acids associated with gut microbial dysbiosis in a subset of patients with diarrhea.

Authors:  Eric J Battaglioli; Vanessa L Hale; Jun Chen; Patricio Jeraldo; Coral Ruiz-Mojica; Bradley A Schmidt; Vayu M Rekdal; Lisa M Till; Lutfi Huq; Samuel A Smits; William J Moor; Yava Jones-Hall; Thomas Smyrk; Sahil Khanna; Darrell S Pardi; Madhusudan Grover; Robin Patel; Nicholas Chia; Heidi Nelson; Justin L Sonnenburg; Gianrico Farrugia; Purna C Kashyap
Journal:  Sci Transl Med       Date:  2018-10-24       Impact factor: 17.956

6.  Impact of malignancy on Clostridium difficile infection.

Authors:  M S Chung; J Kim; J O Kang; H Pai
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2016-07-26       Impact factor: 3.267

7.  Characterization of toxin A-negative, toxin B-positive Clostridium difficile isolates from outbreaks in different countries by amplified fragment length polymorphism and PCR ribotyping.

Authors:  Renate J van den Berg; Eric C J Claas; Duddy H Oyib; Corné H W Klaassen; Lenie Dijkshoorn; Jon S Brazier; Ed J Kuijper
Journal:  J Clin Microbiol       Date:  2004-03       Impact factor: 5.948

8.  Development of large intestinal attaching and effacing lesions in pigs in association with the feeding of a particular diet.

Authors:  N A Neef; S McOrist; R J Lysons; A P Bland; B G Miller
Journal:  Infect Immun       Date:  1994-10       Impact factor: 3.441

9.  New rapid identification test for Clostridium difficile.

Authors:  S T Aspinall; S F Dealler
Journal:  J Clin Pathol       Date:  1992-11       Impact factor: 3.411

10.  Clostridium difficile in retail ground meat, Canada.

Authors:  Alexander Rodriguez-Palacios; Henry R Staempfli; Todd Duffield; J Scott Weese
Journal:  Emerg Infect Dis       Date:  2007-03       Impact factor: 6.883

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.